$PBIO sold more than 350 of its flagship Barocycler instruments to date at a rate of roughly 20-25 instruments per year since 2009. While impressive, these installations only scratch the surface of management's target market of 80,000+ laboratories leaving significant opportunity. The long opinion leader investment phase has probably limited investor appeal to some degree, but we believe that the recent addition of two new technology platforms to its portfolio, opening new market opportunities, marks a significant change in the Company s outlook. https://s1.q4cdn.com/460208960/files/News/201..._Senko.pdf